Cargando…

Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622

BACKGROUND: Sevoflurane (Sev), a commonly used volatile anesthetic, has been reported to inhibit the process of colorectal cancer (CRC). Circular RNAs (circRNAs) are revealed to participate in the pathogenesis of CRC. This study aims to reveal the mechanism of hsa_circ_0000231 in Sev-mediated CRC pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingpeng, Li, Shuyuan, Zhang, Gaofeng, Han, Huihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237491/
https://www.ncbi.nlm.nih.gov/pubmed/34183076
http://dx.doi.org/10.1186/s40709-021-00145-6
_version_ 1783714739325501440
author Wang, Jingpeng
Li, Shuyuan
Zhang, Gaofeng
Han, Huihua
author_facet Wang, Jingpeng
Li, Shuyuan
Zhang, Gaofeng
Han, Huihua
author_sort Wang, Jingpeng
collection PubMed
description BACKGROUND: Sevoflurane (Sev), a commonly used volatile anesthetic, has been reported to inhibit the process of colorectal cancer (CRC). Circular RNAs (circRNAs) are revealed to participate in the pathogenesis of CRC. This study aims to reveal the mechanism of hsa_circ_0000231 in Sev-mediated CRC progression. METHODS: The expression of hsa_circ_0000231 and microRNA-622 (miR-622) was detected by quantitative real-time polymerase chain reaction (qRT-PCR). Protein level was determined by western blot analysis. Cell proliferation was investigated by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), cell colony formation and DNA content quantitation assays. Cell apoptosis was detected by Annexin V-fluorescein isothiocyanate and propidium iodide double staining and caspase 3 activity assays. Cell migration and invasion were investigated by wound-healing and transwell invasion assays, respectively. The putative relationship between hsa_circ_0000231 and miR-622 was predicted by circular RNA Interactome online database, and identified by dual-luciferase reporter and RNA immunoprecipitation assays. The impacts of hsa_circ_0000231 on Sev-mediated tumor formation in vivo were presented by in vivo assay. RESULTS: Hsa_circ_0000231 expression was upregulated, while miR-622 was downregulated in CRC tissues and cells compared with control groups. Sev treatment decreased hsa_circ_0000231 expression, but increased miR-622 expression in CRC cells. Sev treatment suppressed cell proliferation, migration and invasion, and induced cell apoptosis. Hsa_circ_0000231 overexpression restored Sev-mediated CRC progression in vitro. Additionally, hsa_circ_0000231 acted as a sponge of miR-622, and miR-622 inhibitors reversed the impacts of hsa_circ_0000231 silencing on CRC process. Furthermore, Sev treatment inhibited tumor growth by regulating hsa_circ_0000231 in vivo. CONCLUSION: Hsa_circ_0000231 attenuated Sev-aroused repression impacts on CRC development by sponging miR-622. This findings may provide an appropriate anesthetic protocol for CRC sufferers undergoing surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40709-021-00145-6.
format Online
Article
Text
id pubmed-8237491
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82374912021-06-29 Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622 Wang, Jingpeng Li, Shuyuan Zhang, Gaofeng Han, Huihua J Biol Res (Thessalon) Research BACKGROUND: Sevoflurane (Sev), a commonly used volatile anesthetic, has been reported to inhibit the process of colorectal cancer (CRC). Circular RNAs (circRNAs) are revealed to participate in the pathogenesis of CRC. This study aims to reveal the mechanism of hsa_circ_0000231 in Sev-mediated CRC progression. METHODS: The expression of hsa_circ_0000231 and microRNA-622 (miR-622) was detected by quantitative real-time polymerase chain reaction (qRT-PCR). Protein level was determined by western blot analysis. Cell proliferation was investigated by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), cell colony formation and DNA content quantitation assays. Cell apoptosis was detected by Annexin V-fluorescein isothiocyanate and propidium iodide double staining and caspase 3 activity assays. Cell migration and invasion were investigated by wound-healing and transwell invasion assays, respectively. The putative relationship between hsa_circ_0000231 and miR-622 was predicted by circular RNA Interactome online database, and identified by dual-luciferase reporter and RNA immunoprecipitation assays. The impacts of hsa_circ_0000231 on Sev-mediated tumor formation in vivo were presented by in vivo assay. RESULTS: Hsa_circ_0000231 expression was upregulated, while miR-622 was downregulated in CRC tissues and cells compared with control groups. Sev treatment decreased hsa_circ_0000231 expression, but increased miR-622 expression in CRC cells. Sev treatment suppressed cell proliferation, migration and invasion, and induced cell apoptosis. Hsa_circ_0000231 overexpression restored Sev-mediated CRC progression in vitro. Additionally, hsa_circ_0000231 acted as a sponge of miR-622, and miR-622 inhibitors reversed the impacts of hsa_circ_0000231 silencing on CRC process. Furthermore, Sev treatment inhibited tumor growth by regulating hsa_circ_0000231 in vivo. CONCLUSION: Hsa_circ_0000231 attenuated Sev-aroused repression impacts on CRC development by sponging miR-622. This findings may provide an appropriate anesthetic protocol for CRC sufferers undergoing surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40709-021-00145-6. BioMed Central 2021-06-28 /pmc/articles/PMC8237491/ /pubmed/34183076 http://dx.doi.org/10.1186/s40709-021-00145-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Jingpeng
Li, Shuyuan
Zhang, Gaofeng
Han, Huihua
Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622
title Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622
title_full Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622
title_fullStr Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622
title_full_unstemmed Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622
title_short Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622
title_sort sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated mir-622
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237491/
https://www.ncbi.nlm.nih.gov/pubmed/34183076
http://dx.doi.org/10.1186/s40709-021-00145-6
work_keys_str_mv AT wangjingpeng sevofluraneinhibitsmalignantprogressionofcolorectalcancerviahsacirc0000231mediatedmir622
AT lishuyuan sevofluraneinhibitsmalignantprogressionofcolorectalcancerviahsacirc0000231mediatedmir622
AT zhanggaofeng sevofluraneinhibitsmalignantprogressionofcolorectalcancerviahsacirc0000231mediatedmir622
AT hanhuihua sevofluraneinhibitsmalignantprogressionofcolorectalcancerviahsacirc0000231mediatedmir622